SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

H1 Trading Update

22 Apr 2026 07:00

RNS Number : 3805B
Cerillion PLC
22 April 2026
 

AIM: CER

Cerillion plc

("Cerillion" or the "Company")

 

Half-Year Trading Update

 

Cerillion plc, the billing, charging and customer relationship management software solutions provider, announces an update on trading for the first six months of its current financial year ending 30 September 2026.

 

The dominant feature of the first half was the signing in January of Omantel as a major new client in a contract worth c. £42.5m1 over its term. As previously reported, this is Cerillion's largest win to date and another valuable reference customer. Software implementation remains on track and the contract is expected to contribute significantly in the second half of the financial year.

 

Like last year, the Company's full year results are expected to be strongly weighted to the second half of the financial year, with H1 revenue expected to be c. £18.0m (H1 2025: £20.9m) and H1 EBITDA c. £6.2m (H1 2025: £9.9m). This reflects the timing of contracts and the fact that, as anticipated, very little high-margin software licence revenue was recognised in H1 2026. The expected stronger performance in H2 is underpinned by the anticipated unwinding of the very strong back-order book. New orders2 have doubled to £39.6m as at 30 March 2026 (H1 2025: £19.6m), driven principally by the January win, but also by demand from existing customers. The Company's net cash at the half-year end was higher year-on-year at approximately £32.5m (31 March 2025: £31.2m).

 

Given progress to date, the expected income mix in the second half and anticipated new orders from existing customers, the Board believes that Cerillion remains well-positioned to meet market expectations for the financial year. In addition, the pipeline of new business opportunities remains strong, and the Company continues to invest in the business to support growth.

 

Interim results will be published on 1 June 2026, when a further update on current trading and prospects will be provided.

 

Notes

1 The contract with Omantel is denoted in Omani Rials ("OMR") and the spot exchange rate price used to convert its value to from OMR to Pound Sterling ("GBP") is 1 OMR to 1.93 GBP.

2New orders does not include revenue from maintenance and support.

 

 

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Panmure Liberum Limited (Nomad and Joint Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Freddie Wooding

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Moat, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

Cerillion has a 26-year track record in providing mission-critical software for billing, charging and customer relationship management ("CRM"), mainly to the telecommunications sector. The Company has c. 70 customer installations across c. 45 countries.

 

Headquartered in London, Cerillion also has operations in India and Bulgaria as well as a sales presence in Continental Europe, the USA, Singapore and Australia.

 

The business was originally part of Logica plc before its management buyout, led by CEO, Louis Hall, in 1999. The Company joined AIM in March 2016. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIBMFTMTITBMF
Date   Source Headline
8th Jun 20265:50 pmRNSPDMR Dealing
1st Jun 20267:00 amRNSInterim Results
19th May 20267:00 amRNSInterim Results Investor Presentation
24th Apr 20262:46 pmRNSTR-1 Notification
22nd Apr 20267:00 amRNSH1 Trading Update
17th Apr 20268:00 amRNSExcercise of Options, Total Voting Rights
14th Apr 20267:00 amRNSCFO Joining Date and Date of Trading Update
9th Apr 202611:43 amRNSTR-1 Notification
27th Mar 20267:00 amRNSTR-1 Notification
26th Mar 20267:00 amRNS-RAchieves "Diamond-level" Open API Certification
5th Mar 202611:44 amRNSGrant of Options
19th Feb 20263:38 pmRNSResult of AGM
18th Feb 20267:00 amRNSNotification of Major Interest in Cerillion
13th Feb 202610:24 amRNSExercise of Options, Total Voting Rights
6th Feb 202610:37 amRNSExercise of Options, TVR, Block Admission Return
2nd Feb 202612:45 pmRNSExercise of Options and Total Voting Rights
28th Jan 20267:00 amRNSBoard Change - CFO Transition
14th Jan 20266:15 pmRNSExcercise of Options and Share Purchase
12th Jan 20269:15 amRNSPosting of Report and Accounts & Notice of AGM
8th Jan 20267:00 amRNSMajor Contract Win
2nd Dec 20255:19 pmRNSTR-1 Notification
24th Nov 20255:56 pmRNSExcercise of Options, PDMR Dealing
24th Nov 20257:00 amRNSFinal Results
3rd Nov 20257:00 amRNSNotice of Final Results
29th Oct 20257:00 amRNS-RLaunch of Cerillion 25.2
23rd Oct 20258:01 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFull Year Trading Update
25th Sep 20257:00 amRNS-RNamed in IDC MarketScape 2025 Assessment
8th Sep 20257:00 amRNSMajor follow-on contracts worth £17.3m
2nd Sep 20257:00 amRNS-RCerillion Recognised in two Gartner Reports
30th Jul 20257:00 amRNSExercise of Options, PDMR dealing and TVR
2nd Jul 20251:14 pmRNSEmployee Share Option Scheme and PDMR dealing
16th Jun 20257:00 amRNSTR-1 Notification
13th Jun 20257:47 amRNSPDMR shareholding - replacement
12th Jun 20251:50 pmRNSResult of Secondary Share Sale
11th Jun 20254:54 pmRNSProposed Secondary Placing
10th Jun 20256:30 pmRNSPDMR Shareholding
5th Jun 20257:37 amRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSInterim Results
16th May 20251:29 pmRNSResult of General Meeting
12th May 20257:00 amRNSNotice of Results and Investor Presentation
30th Apr 20259:06 amRNSNotice of General Meeting
29th Apr 20253:51 pmRNSTR-1 Notification
14th Apr 20257:00 amRNSHalf-year Trading Update
17th Mar 20257:00 amRNSShare Purchase
13th Feb 20254:25 pmRNSResult of AGM
24th Jan 20259:51 amRNSPDMR Shareholding
22nd Jan 20259:35 amRNSPDMR Shareholding
20th Jan 20257:00 amRNSMajor New Contract
15th Jan 20257:00 amRNSShare purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.